T 0877/03 (Anti-CD30 antibodies/ROCHE) of 07.04.2005
- European Case Law Identifier
- ECLI:EP:BA:2005:T087703.20050407
- Date of decision
- 7 April 2005
- Case number
- T 0877/03
- Petition for review of
- -
- Application number
- 96900937.2
- IPC class
- C12P 21/08
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Anti-CD30 antibodies preventing proteolytic cleavage and release of membrane-bound CD30 antigen
- Applicant name
- Roche Diagnostics GmbH
- Opponent name
- medac Gesellschaft für klinische Spezialpräparate mbH
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1) 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973European Patent Convention R 88 1973
- Keywords
- Added subject-matter (no)
Sufficiency of disclosure, novelty, inventive step (yes)
Violation of right to be heard (no) - Catchword
- -
ORDER
For these reasons it is decided:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent in amended form on the basis of the following documents:
- Claims 1 to 10 of the main request filed on 30 July 2003.
- Description: pages 2 to 3 and 5 to 13, line 7, as granted and amended page 4 as filed at the oral proceedings.